tiprankstipranks
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market

Cadrenal Therapeutics, Inc. (CVKD) Stock Investors

49 Followers
Based on 737,305 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CVKD
On average, investors allocate 0.00% of their portfolios to CVKD
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 737,305 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CVKD

1.4%
Last 7
Days
6.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CVKD, out of 737,305 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CVKD Investor Activity

No data currently available
Based on the activity of 13,923 investors who made their portfolios public
The table shows changes in CVKD in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CVKD Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMC Entertainment
5.47%
-0.73%
+4.67%
1.33B
Communication Services
Riot Platforms
5.02%
-0.05%
-0.66%
2.89B
Financial
Bristol-Myers Squibb
3.20%
-0.07%
+1.50%
81.59B
Healthcare
Coherus Biosciences
2.59%
-1.24%
-5.44%
211.10M
Healthcare
Zscaler
3.60%
-0.39%
+0.09%
24.63B
Technology
Boeing
5.78%
-0.86%
-3.49%
105.37B
Industrials
Applied Materials
4.82%
+0.45%
+4.86%
181.37B
Technology
Block
4.21%
-0.71%
-1.52%
40.45B
Technology
ChargePoint Holdings
3.95%
-0.82%
-3.98%
697.48M
Consumer Cyclical
Trade Desk
4.71%
-0.97%
+1.64%
46.69B
Technology
Based on the activity of 737,305 active portfolios
Open your Smart Portfolio

CVKD Investor Analysis

CVKD investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
100.0%
of CVKD holders
are under 35
Average Segment Performance
Average P/E Ratio22.33
Beta5.97
Dividend Yield9.09%
CVKD investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
0.0%
of CVKD holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.35
Beta10.72
Dividend Yield6.64%
CVKD investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
0.0%
of CVKD holders
are over 55
Average Segment Performance
Average P/E Ratio21.12
Beta3.76
Dividend Yield7.19%
Overview of age group and performance of CVKD stock investors
See who invests in CVKD according to age group and performance.

FAQ

How many retail Investors hold CVKD?
<0.1% of TipRanks' retail investors hold CVKD in their portfolios.
    What is CVKD Investor Sentiment?
    CVKD’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CVKD in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of CVKD in the last 7 days.
        What percentage of retail investors changed their holding of CVKD in the last 30 days?
        ▼ 6.3% of TipRanks' retail investors changed their holding of CVKD in the last 30 days.
          What is the average age of retail investors who hold CVKD?
          The average age of CVKD Holders is under 35.
            What other stocks have CVKD investors also bought?
            CVKD Investors also bought AMC, RIOT, BMY, CHRS, ZS, BA, AMAT, SQ, CHPT, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              BCRXBioCryst
              BSXBoston Scientific
              CRLCharles River Labs
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis